Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

被引：22
作者：
Ahmed, Yousuf [1 ]
Tian, Meijuan [1 ]
Gao, Yong [1 ]
机构：
[1] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada
来源：
AIDS RESEARCH AND THERAPY | 2017年 / 14卷
关键词：
HIV-1; Diversity; Broadly neutralizing antibody; Polyvalent vaccine; B cell maturation; HUMAN-IMMUNODEFICIENCY-VIRUS; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; RHESUS-MONKEYS; SUBTYPE-B; INFECTION; RESPONSES; PROTECTION; SELECTION; IDENTIFICATION;
D O I：
10.1186/s12981-017-0178-3
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The extreme HIV diversity posts a great challenge on development of an effective anti-HIV vaccine. To solve this problem, it is crucial to discover an appropriate immunogens and strategies that are able to prevent the transmission of the diverse viruses that are circulating in the world. Even though there have been a number of broadly neutralizing anti-HIV antibodies (bNAbs) been discovered in recent years, induction of such antibodies to date has only been observed in HIV-1 infection. Here, in this mini review, we review the progress in development of HIV vaccine in eliciting broad immune response, especially production of bNAbs, discuss possible strategies, such as polyvalent sequential vaccination, that facilitates B cell maturation leading to bNAb response.
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
    Zhang, Zhiqing
    Li, Shaowei
    Gu, Ying
    Xia, Ningshao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)
  • [42] HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies
    Misra, Milind
    Jeffy, Jeffy
    Liao, Charis
    Pickthorn, Stephanie
    Wagh, Kshitij
    Herschhorn, Alon
    BIOINFORMATICS, 2024, 40 (03)
  • [43] Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure
    Parsons, Matthew S.
    Kristensen, Anne B.
    Selva, Kevin J.
    Lee, Wen Shi
    Amarasena, Thakshila
    Esterbauer, Robyn
    Wheatley, Adam K.
    Bavinton, Benjamin R.
    Kelleher, Anthony D.
    Grulich, Andrew E.
    Khoury, Georges
    Juno, Jennifer A.
    Kent, Stephen J.
    EBIOMEDICINE, 2021, 70
  • [44] Tracking the development of broadly neutralizing antibodies
    Gruell, Henning
    Klein, Florian
    NATURE MEDICINE, 2014, 20 (05) : 482 - 483
  • [45] Correlates of broadly neutralizing antibody development
    Abela, Irene A.
    Kadelka, Claus
    Trkola, Alexandra
    CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 279 - 285
  • [46] Approaches to the induction of HIV broadly neutralizing antibodies
    Moore, Penny L.
    Williamson, Carolyn
    CURRENT OPINION IN HIV AND AIDS, 2016, 11 (06) : 569 - 575
  • [47] The expanding array of HIV broadly neutralizing antibodies
    Laura E. McCoy
    Retrovirology, 15
  • [48] The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development
    Zhang, Yu
    Yuan, Tingting
    Li, Jingjing
    Zhang, Yanyu
    Xu, Jianqing
    Shao, Yiming
    Chen, Zhiwei
    Zhang, Mei-Yun
    AIDS, 2013, 27 (16) : 2529 - 2539
  • [49] HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies
    Serwanga, Jennifer
    Ssemwanga, Deogratius
    Muganga, Michael
    Nakiboneka, Ritah
    Nakubulwa, Susan
    Kiwuwa-Muyingo, Sylvia
    Morris, Lynn
    Redd, Andrew I.
    Quinn, Thomas C.
    Kaleebu, Pontiano
    VACCINE, 2018, 36 (04) : 578 - 586
  • [50] The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention
    Thavarajah, Jannifer Jasmin
    Honge, Bo Langhoff
    Wejse, Christian Morberg
    VIRUSES-BASEL, 2024, 16 (06):
12345